Evans & Dixon’s Denise Bloch authored the below article that was recently published by the St. Louis Metropolitan Medicine in its December 2020/January 2021 issue.
Federal alert indicates increased focus on speaker programs and their
potential to violate the anti-kickback statute
On November 16, 2020, the U.S. Office of Inspector General (OIG) issued a Special Fraud Alert 1 focusing on the fraud and abuse risks related to payment, solicitation or receipt of remuneration from speaker programs conducted by pharmaceutical and medical device companies. This special alert provides notice to health care providers and companies that the OIG will be focusing
Continue Reading Beware of Pharmaceutical and Medical Device Speaker Programs